Bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers
Yang Shui-yua
Abstract
Yang Shui-yua
Abstract
Objective To inspect the bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers.Methods A single(2 g)and multiple(1 g)oral of Enteric-coated Tablets and reference tablets were given to 20 healthy male cvolunteers according to randomized crossover design.Tinidaxole in plasma was determined by HPLC methods.The pharmacokinetic parameters and bioavailability of and reference tables.Results after a single oral of 2 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(881.7±147.5)and(974.5±146.9)mg/(h·L),Cmax was(33.83±6.50)and(47.94±8.68)mg/L,tmax was(10.60±1.93)and(1.63±0.46)h,respectively.The relative bioavailability of Enteric-coated Tablets was(90.91±11.29)%.After multiple oral administration 1 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(1277.9±289.8)and(1191.6±288.0)mg/(h·L),Cmax was(47.74±10.34)and(55.14±9.01)mg/L,tmax was(10.06±1.86)and(1.44±0.64)h,respectively.The relative bioavailability of Enteric-coated Tablets was(109.55±20.58)%.Conclusion The 2 preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To inspect the bioequivalence of Tinidaxole-colon-Positioning Enteric-coated Tablets in healthy volunteers.Methods A single(2 g)and multiple(1 g)oral of Enteric-coated Tablets and reference tablets were given to 20 healthy male cvolunteers according to randomized crossover design.Tinidaxole in plasma was determined by HPLC methods.The pharmacokinetic parameters and bioavailability of and reference tables.Results after a single oral of 2 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(881.7±147.5)and(974.5±146.9)mg/(h·L),Cmax was(33.83±6.50)and(47.94±8.68)mg/L,tmax was(10.60±1.93)and(1.63±0.46)h,respectively.The relative bioavailability of Enteric-coated Tablets was(90.91±11.29)%.After multiple oral administration 1 g Enteric-coated Tablets and reference tables,the pharmacokinetic parameters were as follows:AUC0-84 was(1277.9±289.8)and(1191.6±288.0)mg/(h·L),Cmax was(47.74±10.34)and(55.14±9.01)mg/L,tmax was(10.06±1.86)and(1.44±0.64)h,respectively.The relative bioavailability of Enteric-coated Tablets was(109.55±20.58)%.Conclusion The 2 preparations are bioequivalent.
Key concepts: Bioequivalence, Bioavailability, Cmax, Pharmacokinetics, Enteric coated, Enteric coating, Crossover study, Dosage form